Abstract
Transmembrane G-protein coupled receptors (GPCRs) are ideal drug targets because they resemble, in function, molecular microprocessors for which outcomes (e.g. disease pathways) can be controlled by inputs (extracellular ligands). The inputs here are ligands in the extracellular fluid and possibly chemical signals from other sources in the cellular environment that modify the states of molecular switches, such as phosphorylation sites, on the intracellular domains of the receptor. Like in an engineered microprocessor, these inputs control the configuration of output switch states that control the generation of downstream responses to the inputs.
Many diseases with heterogeneous prognoses including, for example, cancer and diabetic kidney disease, require precise individualized treatment. The success of precision medicine to treat and cure disease is through its ability to alter the microprocessor outputs in a manner to improve disease outcomes. We previously established ab initio a model based on maximal information transmission and rate of entropy production that agrees with experimental data on GPCR performance and provides insight into the GPCR process. We use this model to suggest new and possibly more precise ways to target GPCRs with potential new drugs.
We find, within the context of the model, that responses downstream of the GPCRs can be controlled, in part, by drug ligand concentration, not just whether the ligand is bound to the receptor. Specifically, the GPCRs encode the maximum ligand concentration the GPCR experiences in the number of active phosphorylation or other switch sites on the intracellular domains of the GPCR. This process generates a memory in the GPCR of the maximum ligand concentration seen by the GPCR. Each configuration of switch sites can generate a distinct downstream response bias. This implies that cellular response to a ligand may be programmable by controlling drug concentration. The model addresses the observation paradox that the amount of information appearing in the intracellular region is greater than amount of information stored in whether the ligand binds to the receptor. This study suggests that at least some of the missing information can be generated by the ligand concentration. We show the model is consistent with assay and information-flow experiments.
In contrast to the current view of switch behavior in GPCR signaling, we find that switches exist in three distinct states: inactive (neither off nor on), actively on, or actively off. Unlike the inactive state, the active state supports a chemical flux of receptor configurations through the switch, even when the switch state is actively off. Switches are activated one at a time as ligand concentration reaches threshold values and does not reset because the ligand concentration drops below the thresholds. These results have clinical relevance. Treatment with drugs that target GPCR-mediated pathways can have increased precision for outputs by controlling switch configurations. The model suggests that, to see the full response spectrum, fully native receptors should be used in assay experiments rather than chimera receptors.
Inactive states allow the possibility for novel adaptations. This expands the search space for natural selection beyond the space determined by pre-specified active switches.
You have full access to this open access chapter, Download conference paper PDF
1 Introduction
Protein receptors that span the cell membrane are molecular microprocessors [20]. They gather information from outside the cell and process and transmit the information to the intracellular space, where it is directed to chemical pathways that lead to cellular response to extracellular conditions. The molecular microprocessors are programmed by natural selection and chemical conditions within the organism. For disease control, the programming is achieved mostly through the directed application of drugs. It requires higher-resolution drug targets and increased understanding of the effects of high-resolution drug targeting [2].
The most important class of these transmembrane receptors, both scientifically and medically, are the G-protein coupled receptors (GPCRs). More than 30% of all prescription drugs target GPCRs [18]. The advent of precision medicine has increased the importance of understanding how information can be controlled at higher levels of resolution. As an example, the hormone angiotensin II increases blood pressure and prolonged hypertension drives diabetic kidney disease (DKD). Renin angiotensin system inhibitors (RASi), such as angiotensin converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) block the formation and action of angiotensin II and lower systemic blood pressure. Interestingly, when compared with other antihypertensive agents, ACEIs and ARBs stabilize kidney function at the same level of achieved blood pressure better than conventional antihypertensive therapy [22]. This suggests that angiotensin II also operates in other processes [2, 13]. Indeed, the angiotensin receptor and other G-protein coupled receptors can trigger distinct multiple downstream responses that depend on the cellular environment [6, 11, 17] and thereby may lead to heterogeneous disease progression and effect of therapy.
As the angiotensin example illustrates, the era of precision medicine requires much higher resolution drug targeting to reduce the heterogeneity of disease progression. This requires a better understanding of the details of how the information is processed by GPCRs. Recent attempts [6] at making progress on this ambitious goal have relied on teleonomy, the imparting of goals to natural selection. In this case, a model was developed that imparted goals of maximal rate of energy production and information transmission. In this study, we use the model developed in [6] to improve the resolution of GPCR information processing and increase our understanding of how this resolution can be used to program the molecular microprocessors to individualize patient treatments for improved prognosis.
Information is a type of entropy [5, 7, 10, 21]. Systems in equilibrium are those in which entropy is maximized and entropy flow is zero. Systems in equilibrium are not alive. Living systems are those in which entropy, and hence information, flows. Entropy flow can occur, for instance, when a chemical concentration is far from its equilibrium value as is the case with adenosine triphosphate (ATP) in biological systems. Entropy and information flow can also occur in the presence of spatial gradients such as those found at cell membranes. Both types of entropy flow are important in this study. Figure 1A illustrates a case in which information flows across a cell membrane. Figure 1C illustrates an active phosphorylation switch in which a chemical flux is driven by excess of ATP.
Information contained in the extracellular space is transmitted to the intracellular space by receptors (Fig. 1A). Ligands, such as hormones, auxins, nutrients, neurotransmitters, and many other molecules in the extracellular fluid, announce their presence to the cell by binding to extracellular domains of the receptor and allosterically altering the intracellular properties of the receptor. The intracellular changes in the receptor effect the cell’s response to the ligand stimulus. In many cases, the extracellular changes take the form of phosphorylated and unphosphorylated sites on the C tail of the receptor protein (Figs. 1B and C) [11]. The sites form a barcode that is read by intracellular processes that respond to the information in the code [3, 4, 11, 23,24,25,26]. Other receptor conformations are possible but the barcode process described here is a good representative exemplar.
A number of questions emerge. How is the barcode programmed? In other words, which sites are phosphorylated and which are unphosphorylated? How many active sites, or switches, are there? How is the phosphorylation state of the barcode changed? What determines the number of active phosphorylation sites and how is that number changed? The issue is that any set of molecules that store information, as does the barcode, must be stable to thermal and other fluctuations [19]. Yet, rearrangement of the barcode must be possible. Since many phosphorylation sites may be present, this requires a significant amount of energy to effect a global change. Typically sites are phosphorylated and dephosphorylated by catalyst kinases and phosphatases, respectively. How can both kinases and phosphatases act in global concert to change the information content across an entire barcode of several phosphorylation switches?
A. A ligand binds to the extracellular domains of a receptor that spans the cell membrane. A number of phosphorylation sites occupy the C tail of the receptor. Some of the sites are inactive (not shown); some are active and phosphorylated (designated by P); and some are active and unphosphorylated. Phosphorylated sites are designated on, while unphosphorylated states are designated off. The site labeled G is a GTPase switch found in G-protein coupled receptors (GPCRs). B. An inactive PdPC switch. Every physical path from unphosphorylated (off) to phosphorylated (on) has a microscopically reversed path. The chemical flux in the forward path is equal to the flux in the microscopically reversed path. The flux is in detailed balance and the reaction is in equilibrium. C. An active PdPC switch. The reactions in a forward circular direction have significant chemical flux \(J_0\) and are catalyzed by kinases and phosphatases. The microscopically reversed pathways in the opposite direction have negligible flux and are not displayed. The switch is driven far from equilibrium by the flux \(J_0\).
This study attempts to address some of these questions. Our approach is grounded in recent theoretical work [6] fitting biochemical data [17], site-directed spectroscopy observations [11], molecular dynamic simulations [11] and information-flow measurements [9]. Our approach differs from the mass-action-driven modeling approaches on signaling bias, e.g. [1], thus it may be unfamiliar to some due to its new approach and its heavy reliance on non-equilibrium thermodynamic principles. However, the fundamentals of the original model are well described by [6]. Therefore, we only introduce here some of the relevant features of the approach in Figs. 1 and 2. The new findings are illustrated and supported by data in Table 1 and Figs. 3 and 4. Briefly, we show that in addition to information for output (e.g. effector coupling, MAPK cascading, gene expression) induced by ligand binding to the GPCR, the dynamics of ligand concentration presented to this receptor, both concentration and time, provide information that is transmitted to downstream responses. Consequently, new drug presentation strategies may provide an additional tool in targeting GPCRs for disease control.
2 Approach and Results
2.1 Relation Between Ligand Concentration and Number of Active Phosphorylation Sites
We build on the study in [6]. That work used maximum entropy production along with maximum information storage and transfer to generate the bag-of-independent-switches (BOIS) model picture, which imposes a number of constraints on the barcode. The model predicts that three switch configurations are possible, on, off, and inactive and that the phosphorylation sites (switches) are effectively uniform, except for a small number of differences that divide the switches into the three configurations. Active switches are distinguished from inactive switches in that active switches support a finite chemical flux through the switches [16], while inactive switches have zero flux Fig. 1B and C). Active switches are divided into phosphorylated (on) and unphosphorylated (off) sites. The chemical flux in active switches serves as a local energy/heat source that drives the process. The basic exemplar switch is a phosphorylation-dephosphorylation cycle (PdPC) [16] displayed in Fig. 1B for the inactive switch and Figure C for an active switch. The number of switches N, in this case, is equal to the number of phosphorylation sites on the C tail. The receptor concentration is designated \(R_T\).
For a receptor that has never been exposed to a particular ligand, all switches in the barcode are inactive with no chemical flux. As ligand concentration increases, the switches activate one at a time (Fig. 2). The first switch activates when the receptor concentration reaches an experimentally accessible [17] reference concentration of \(R_{ref} = R_T / N\) that is independent of the type of ligand or the ligand concentration [6]. As ligand concentration increases, the switches activate one-by-one until all N switches are activated. If the ligand concentration is then reduced, the switches that have been activated do not deactivate. This is conceptually similar to a ratchet and pawl that ratchets to a higher number of activated states (Supplement A.1).
ratchet. A. Early time, low ligand concentration. The ligand-bound core concentration \(R_L=0\). The concentration of active switches \(R_A =0\) All switches are inactive (I). B. As ligand concentration increases, the ligand-bound core concentration \(R_L\) approaches the reference concentration \(R_{ref}\). C. When the ligand-bound core concentration \(R_L\) equals \(R_{ref}\), the core concentration \(R_L\) goes to zero and the concentration \(R_A\) of active switches goes to \(R_{ref}\). D. The process repeats until the number M of active switches is equal to the number pf phosphorylation sites N. At any given time the concentration of active switches is \(R_A = M\;R_{ref}\). The number of active switches M does not decrease when the ligand concentration decreases.
According to the BOIS model, the maximum concentration \(L^*\) that the ligand reaches, the total number N of switches, and the number M of activated switches obey the relationship (Supplement A.2)
where \(K_D\) is the ligand/receptor dissociation constant. Equation 1 is a constraint on the number of activated switches M. If the ligand concentration is very large, \(L_{max} \gg K_D\), then all the phosphorylation sites are activated, \(M=N\). If the receptor has never encountered the ligand, \(L^* =0\), then the arguments of Supplement A.2 indicate that no switches are activated and \(M=0\). The predicted value for M is the minimum value of M for which the inequality Eq. 1 is true. This can be written
where floor chooses the largest integer less than the argument. When the maximum ligand concentration is zero, \(M=0\). When the argument of floor becomes slightly greater than one, then \(M=1\). When the maximum ligand concentration becomes very large, then \(M=N\). The ligand concentrations L(M) at which switch M turns on is determined by
The quantity \(L^*(M)\) can be approximated by the half-maximal effective concentration EC\(_{50}(M)\) for switch M. This prediction is consistent with observations that significant downstream response can be observed even when a significant fraction of receptors are not engaged causing EC\(_{50}\) values to be potentially much smaller than the value of the dissociation constant \(K_D\) [27].
We see from Eq. 2 that an approximation of the value of the largest ligand concentration the receptor has encountered is coded into the number of active switches, according to the BOIS model. The amount of information per bit \(I_{M}\) stored in this manner is (Supplement A.2)
where M is given by Eq. 2. The BOIS model thus provides a mechanism for encoding and transmitting information related to extracellular ligand concentration. The maximum information \(I_B\) stored in the binding of ligand with the receptor is
Therefore, the amount of information we have identified in the extracellular fluid that can be transmitted to the intracellular fluid is the sum of Eqs. 4 and 5. This extra information about the maximum ligand concentration may contribute to the observed excess transmitted information [9].
2.2 Application to G-Protein Coupled Receptors
An important GPCR feature, in the context of this study, is that, in addition to the barcode on the C tail, there is a GTPase switch [16] that activates particular downstream responses to ligand stimuli [14].
The BOIS model predictions of the previous section can be compared with GPCR assay observations [17]. The results are summarized in Table 1 and Fig. 3. The assays examined the response in two receptors, adrenergic and angiotensin, when tested with several ligands. The responses in two downstream pathways were measured, the response to the \(G_{\alpha }\) GTPase switch turning on and the response of the recruitment of \(\beta \) arrestin (\(\beta \)arr) to the C tail barcode of the receptor GPCR [12]. The \(\beta \)arr is thought to be a scaffold for other responses mediated by the barcode [12]. To reduce noise, the C tails of the light receptors in the assay were replaced with C tails of the vasopressin. Receptors with this alternate tail are known as chimeric. While the \(\beta \)arr recruitment site was preserved, the remaining phosphorylation sites on the C tail may not have been preserved on the chimeric-receptor tail.
The ligand concentration was slowly increased from 0 molar to a concentration at which the response was saturated. It was found that the maximum response was approximately equal to a common reference concentration \(R_{ref}\) for each receptor in agreement with the BOIS predictions [6]. This can be seen in Fig. 3C and D where the maximum values of the response concentrations normalized to \(R_{ref}\) are found at the corners, (00), (10), (01), and (11), of a hypercube. Moreover, the switches turned on one at a time also as indicated by the BOIS model (Table 1, Fig. 3A and B). In the case we have here in which the ligand concentration of the second switch is much greater than the ligand concentration of the first switch, then, from Eq. 2, the dissociation constant \(K_D\) is approximately the \(L^*(1) = EC_{50}(1)\) of the first switch, which is given in Table 1 as \(10^{-9.44}\) M for the adrenergic receptor and \(10^{-8.06}\) M for the angiotensin II receptor. This implies, from Eq. 3, that the total number N of switches is
This means that the experimenters [17] observed all the states in the two receptors that were affected by the increasing ligand concentration. Moreover, it implies that the replacement of the adrenergic and angiotensin II C tails with vasopressin tails did not preserve the ability of the barcode to trigger responses other than \(\beta \)arr recruitment.
A. Adrenergic Receptor with Formoterol as Ligand. Here, L is the ligand concentration. The theory is displayed in red. The dashed line is the simulation of the activation of the first switch. The dotted curve is the activation of the second switch. The yellow markers are the observed assay dose response for the \(G_{\alpha }\) pathway. The cyan markers are the observed assay dose response for \(\beta \) arr. B. Angiotensin II Receptor with Angiotensin II as Ligand. C. Bias Plot for All Ligands for Adrenergic Receptor (see Table 1). The simulation results are displayed in red. Note that some ligands are \(G_{\alpha }\) biased; their endpoints lie close to the \(G_{\alpha }\) axis. Other ligands are balanced; their endpoints lie at (1,1). No \(\beta \) arr bias is seen in this set of ligands. D. Bias Plot for All Ligands for angiotensin II Receptor. This plot illustrates balanced bias and \(\beta \) arr bias. For balanced bias the first switch is the GTPC and the second switch is the PdPC that activates arrestin recruitment. For \(\beta \) arr bias, the GTPC is not activated. The BOIS model predicts that the first ACTIVATED is a PdPC that is not observed. Here, \(G_{\alpha }\) bias is only seen for ligand concentrations that are associated with sub-maximal response.
From Eq. 4, we see that two bits (\(2\log _2 2\)) of information is transmitted across the cell membrane to the intracellular space.
BOIS interpretation of bias data. Ligands can be classified by whether the response is balanced or biased. The upper curve is the response for balanced ligands. The lower curve is the response for biased ligands. The system supports two switches that activate sequentially. For low initial values of ligand concentration, all switches are inactive. As ligand concentration increases, the first switch is activated. For balanced ligands, the first switch observed to be activated is \(G_{\alpha }\), while for biased ligands the first switch can be either \(G_{\alpha }\) A. or \(\beta \)arr B.. For biased ligands, the first switch is activated in the off state. For the adrenergic receptor A., The \(G_{\alpha }\) switch does not need to be activated in order to activate the \(\beta \)arr switch into the off state for biased ligands. After the first switch activates, but before the second switch activates, half the switches are active and half are inactive. As ligand concentration increases further, the second switch activates activating the \(\beta \)arr recruitment pathway for balanced ligands and the remaining inactive pathways for the biased ligands. Note that the BOIS model predicts that if the ligand concentration is lowered from its maximum that the activated switches do not deactivate. Therefore, the number of active switches is a measure of the maximum ligand concentration.
The BOIS model predicts that these receptors are able to detect if a ligand is attached and whether the ligand concentration is greater than or less than the half maximal effective concentration EC\(_{50}(1)\) for the first switch.
Four distinct responses were observed, a balanced response to the bound ligand in which both the \(G_{\alpha }\) switch and the \(\beta \)arr recruitment switch turn on (purple row in Table 1), a situation in which just the \(G_{\alpha }\) switch turned on (red cells), a situation in which just the \(\beta \)arr switch turned on (blue), and a situation in which no switches turned on (yellow). For the balanced ligands, both switches are seen to activate, first the \(G_{\alpha }\) switch and then the \(\beta \)arr recruitment switch (Fig. 4). The first switches to activate in the case of biased ligands is now observed, however. The adrenergic receptor responds with \(G_{\alpha }\) response when the second switch activates, while the angiotensin II receptor responds with the \(\beta \)arr recruitment response when the second switch activates.
The BOIS model predicts that, for biased ligands in these observations, the first switch is activated, but set to the off state. In other words, the switch sites are absorbing energy and dissipating heat but they are in the off position. This means, for example, that if the switch is a phosphorylation site, it is active and generating chemical flux through the site but the site spends most of its time unphosphorylated and not activating downstream response.
The BOIS model predicts that, for the one ligand that displayed no response, the switches may have been activated but they were in the off state.
3 Discussion
This study starts from an abstract model, the BOIS model [6] that was built on the assumptions of maximum rate of entropy production and maximum storage and flow of information. To validate the model with experiment, the BOIS model was specialized in [6] to address information flow in GPCRs. The process of this specialization was continued in this study and further hypotheses were generated that were compared with assay observations of [17] and information-flow experiments [28].
Specifically, switches can exist as phosphorylation sites on the C tail or on the GPCR or they can exist as GTPase switches on the core of the receptor. The switches can exist in three distinct states [6], inactive, active/on, and active/off. Active states are distinguished from inactive states in that active states support a chemical flux of receptor states through the switches while the inactive states have zero flux. For switches in the on state the receptor spends most of the time in the phosphorylated state in the case of phosphorylation switches. In the off state, the receptor spends most of the time in the unphosphorylated state.
Each active switch associates with a quantum of the total receptor concentration equal to \(R_{ref} = R_T / N\) where \(R_T\) is the receptor concentration and N is the number of switches. This is true for both inactive and active switches [6]. This is a collective process. Each switch has a local property \(R_{ref}\) affected by a global quantity N, which is non-local. It is not clear how an individual switch gains access to how many switches, active and inactive, there are.
The switches are activated one at a time in units of \(R_{ref}\) as ligand concentration increases from an initial zero value and assuming all switches in the receptor are inactive. Therefore N is the total number of switches than can be activated. Whether a switch is in the on state or to the off state seems to be determined at activation. If a switch becomes activated, then it remains active if the ligand concentration drops. Therefore, the number of active switches is a measure of the maximum concentration the receptor has experienced. The expression for this is given in Eqs. 3 and 4.
These predictions are consistent with experimental observations that significant response can occur when only a small number of total receptors are engaged with active switches [27]. They also suggests that observations that do not use chimeric-receptor C tails may be of importance. Chimeric-receptor tails were used to reduce noise, but the model predicts that the only switches available in assay experiments [17] were the \(\beta \)arr recruitment switch and the \(G_{\alpha }\) switch when chimeric-receptor tails were employed. One expects many more phosphorylation switches [11]. This hints that the native C tails had relevant phosphorylation sites that did not appear on the chimeric-receptor tails. This suggests that the some of the noise that was eliminated by the chimeric-receptor tails was actually signal. If one redoes the assay experiments with native tails and measures more than two downstream responses, then the model predicts a series of signal switches that turn on sequentially and that the EC\(_{50}\)s of those switches would be closer together.
The amount of information transmitted through the membrane, Eq. 4, from the ligand concentration can account for some of the information found missing in information flow measurements [28]. In the observations, two bits or more of information was observed transmitting through the membrane, but if the only source of the information was whether the ligand was bound or not to the receptor, then only one bit, at most, was available to be transmitted. This suggests that there might be information other than simple binding that is associated with the ligand. At least some of the missing information seems to originate with the value of the ligand concentration.
Comparison of the BOIS model with assay experiments [17] indicates that the first switch that is activated may be either a \(G_{\alpha }\) switch or a \(\beta \)arr switch for biased ligands (Fig. 4). For the two receptors observed, the first switch was \(G_{\alpha }\) for balanced ligands and the second switch was for \(\beta \)arr recruitment. Bias may be determined at the time of switch activation. Our small observational sample [17] suggests that the first state activated is activated to the off state and determines the bias, at least in the case of a small number of switches (\(N=2\)).
This picture differs from the canonical model of GPCR activation [15]. In that model, the \(G_{\alpha }\) switches activates and turns on first. Subsequently, the \(\beta \)arr switch activates and turns on. Somewhat surprisingly, for the adrenergic receptor in this study coupled with the assay study [17], the \(G_{\alpha }\) switch does not need to be activated in order to activate the \(\beta \)arr switch into the off state for biased ligands. Within the context of the BOIS model and the assay experiments [17], the \(\beta \)arr switch is first to activate, but it is turned off. The \(G_{\alpha }\) switch may be turned on after the \(\beta \)arr recruitment switch, but the mechanism for this is currently unclear. These observations may also be affected by the information lost in the chimeric-receptor tail.
These results suggest some options for programming the receptor microprocessors with drugs for application in precision medicine. The new information in this study relates to the importance of ligand concentration in determining the downstream response.
In addition to ligand type, downstream response seems to be determined by the ligand concentration. Ligand concentration determines the number of active switches and the downstream response. Presumably there is a different downstream set of responses for each value of the number of active switches. Bias is determined by first switch activated. Ligand selection indicates that ligands determine the \(G_{\alpha }\) pathway and the \(\beta \)arr pathway.
This study indicates that bias can be determined at the time that switches are activated. It is still not clear, however, if or how switch states can be altered between on and off after the switch is activated. Altering switch states at this level is a competition between the longevity and stability requirements for useful information and the need to be able to change the states for adaptability [19].
The observation that a biological switch can have three possible states rather than the two in a Boolean world leads to implications for adaptability. The switches in inactive states are switches that can be either on or off when activated. They represent the possibility of future information encoding for unknown future cell responses. The possible information in the barcode is no longer constrained by the number of active switches that are definitely in on and off states. The number of potential barcode configurations has increased significantly over the number encoded by on and off. This concept of increasing the size of the available search space to respond to future unknown events has been dubbed adjacent possibility [8] and has been suggested to be a necessary requirement for natural selection.
References
Black, J.W., Leff, P.: Operational models of pharmacological agonism. Proc. R. Soc. Lond. Ser. B. Biol. Sci. 220(1219), 141–162 (1983)
Cardon, L.R., Harris, T.: Precision medicine, genomics and drug discovery. Hum. Mol. Genet. 25(R2), R166–R172 (2016)
Chakravorty, D., Assmann, S.M.: G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants. Biochem. J. 475(21), 3331–3357 (2018)
Chen, H., Zhang, S., Zhang, X., Liu, H.: QR code model: a new possibility for GPCR phosphorylation recognition. Cell Commun. Signaling 20(1), 1–16 (2022)
Ebeling, W.: Physical basis of information and the relation to entropy*. Eur. Phys. J. Spec. Top. 226, 161–176 (2017)
Jones, R.D., Jones, A.M.: Model of ligand-triggered information transmission in G-protein coupled receptor complexes. Front. Endocrinol. 14, 879 (2023)
Jones, R.D., Redsun, S.G., Frye, R.E.: Entropy generation by a Maxwell demon in the sequential sorting of the particles in an ideal gas. arXiv preprint physics/0311023 (2003). https://arxiv.org/abs/physics/0311023
Kauffman, S.: Is there a fourth law for non-ergodic systems that do work to construct their expanding phase space? Entropy 24(10), 1383 (2022)
Keshelava, A., et al.: High capacity in G protein-coupled receptor signaling. Nat. Commun. 9(1), 1–8 (2018)
Landauer, R.: The physical nature of information. Phys. Lett. A 217(4–5), 188–193 (1996)
Latorraca, N.R., et al.: How GPCR phosphorylation patterns orchestrate arrestin-mediated signaling. Cell 183(7), 1813–1825 (2020)
Latorraca, N.R., et al.: Molecular mechanism of GPCR-mediated arrestin activation. Nature 557(7705), 452–456 (2018)
Leehey, D.J., Singh, A.K., Alavi, N., Singh, R.: Role of angiotensin II in diabetic nephropathy. Kidney Int. 58, S93–S98 (2000)
Lefkowitz, R.: Nobel lecture: a brief history of G protein coupled receptors. Nobel Lect. 52, 6366–6378 (2012)
Lefkowitz, R.J.: A brief history of G-protein coupled receptors (Nobel lecture). Angew. Chem. Int. Ed. 52(25), 6366–6378 (2013)
Qian, H.: Thermodynamic and kinetic analysis of sensitivity amplification in biological signal transduction. Biophys. Chem. 105(2–3), 585–593 (2003)
Rajagopal, S., et al.: Quantifying ligand bias at seven-transmembrane receptors. Mol. Pharmacol. 80(3), 367–377 (2011)
Santos, R., et al.: A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16(1), 19–34 (2017)
Schrodinger, R., Schrödinger, E., Dinger, E.S.: What is Life?: With Mind and Matter and Autobiographical Sketches. Cambridge University Press, Cambridge (1992)
Smith, J.S., Lefkowitz, R.J., Rajagopal, S.: Biased signalling: from simple switches to allosteric microprocessors. Nat. Rev. Drug Discov. 17(4), 243–260 (2018)
Szilard, L.: On the decrease of entropy in a thermodynamic system by the intervention of intelligent beings. Behav. Sci. 9(4), 301–310 (1964)
Thomas, M.C., Atkins, R.C.: Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs 66, 2213–2234 (2006). https://doi.org/10.2165/00003495-200666170-00005. PMID: 17137404
Tobin, A.: G-protein-coupled receptor phosphorylation: where, when and by whom. Br. J. Pharmacol. 153(S1), S167–S176 (2008)
Tobin, A.B., Butcher, A.J., Kong, K.C.: Location, location, location... site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol. Sci. 29(8), 413–420 (2008)
Tunc-Ozdemir, M., Li, B., Jaiswal, D.K., Urano, D., Jones, A.M., Torres, M.P.: Predicted functional implications of phosphorylation of regulator of g protein signaling protein in plants. Front. Plant Sci. 8, 1456 (2017)
Yang, Z., et al.: Phosphorylation of g protein-coupled receptors: from the barcode hypothesis to the flute model. Mol. Pharmacol. 92(3), 201–210 (2017)
Zhu, B.T.: The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors. J. Pharmacol. Toxicol. Methods 29(2), 85–91 (1993)
Zielińska, K., Katanaev, V.: Information theory: new look at oncogenic signaling pathways. Trends Cell Biol. 29(11), 862–875 (2019)
Acknowledgements
Biological images created with BioRender.com.
Funding
Partially funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011”. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or Innovative Medicines Initiative 2 Joint Undertaking (Grant No. 115974, 2015). Neither the European Union nor the granting authority can be held responsible for them. Research in the laboratory of Alan M. Jones is supported by the National Science Foundation (MCB-0718202) and the National Institute of General Medical Sciences (R01GM065989).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Copyright information
© 2024 The Author(s)
About this paper
Cite this paper
Jones, R.D., Jones, A.M. (2024). A Proposed Mechanism for in vivo Programming Transmembrane Receptors. In: Villani, M., Cagnoni, S., Serra, R. (eds) Artificial Life and Evolutionary Computation. WIVACE 2023. Communications in Computer and Information Science, vol 1977. Springer, Cham. https://doi.org/10.1007/978-3-031-57430-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-57430-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-57429-0
Online ISBN: 978-3-031-57430-6
eBook Packages: Computer ScienceComputer Science (R0)